10.06.2020 • News

Celanese Tests New Acetic Acid Route in China

Celanese Tests New Acetic Acid Route in China (c) Celanese
Celanese Tests New Acetic Acid Route in China (c) Celanese

Celanese (Nanjing) Chemical, a subsidiary of US chemical and specialty materials company Celanese, has agreed with Southwest Institute of Chemical Company (SWCHEM) and Yankuang Lunan Chemical to build a pilot plant in China to test the production at industrial scale of acrylic acid using acetic acid feedstock.

Based on its original proprietary research, Celanese is developing together with SWCHEM a route to produce acrylic acid via the condensation of acetic acid with formaldehyde.  The process is a potential alternative to traditional technologies; the most widely used process for making acrylic acid is the vapor phase oxidation of propylene.

Under the terms of the agreement, Yankuang Lunan will build a pilot facility in Teng Zhou to finish commercial production trials.

“This could create additional demand for acetic acid while also improving the supply options for acrylic acid consumers,” said John Fotheringham, senior vice president of Celanese’s Acetyls business.

Chen Jiang, SWCHEM’s president added: “SWCHEM has a longstanding relationship with Celanese dating back to 2008. This agreement marks the expansion of our cooperation into deeper value chain of the acetyls industry.”

The companies did not disclose a timescale for the project.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.